TikTok's 'best peptides' list gets key facts wrong

What did @pepticore_eu actually say?

Almost nothing, medically speaking. The transcript captured is a repeated phrase, "I'm gonna steal this cold because I'm the only one," which appears to be an audio glitch, a lip-sync artifact, or a misattributed sound. The actual informational content of this video, if any, is not present in the transcript provided. What we do have is a hashtag set pointing to a specific peptide stack: RET (possibly retatrutide), GHK-Cu, CJC-1295, MT-2 (melanotan II), and peptides broadly. The video title calls these the "best peptides." That is a claim, even if it was never spoken aloud.

Hashtag promotion is still promotion. Listing peptide names in a TikTok caption, especially compounds like MT-2, which has no approved therapeutic indication anywhere, is a form of implicit endorsement. That matters.

Does the science back up the "best peptides" framing?

The peptides tagged here span a wide range of evidence quality, from genuinely interesting research compounds to substances with serious safety red flags. Grouping them together as the "best" flattens distinctions that actually matter for anyone making real decisions about their health.

GHK-Cu (copper peptide) has a reasonable body of in-vitro evidence for wound healing and skin remodeling. Pickart and Margolina (2018, Biomedicines) summarized decades of research showing GHK-Cu upregulates collagen synthesis and has antioxidant properties, though most evidence remains preclinical. CJC-1295, a GHRH analogue, was studied in clinical trials by Ionescu and Frohman (2006, Journal of Clinical Endocrinology and Metabolism), showing sustained GH elevation, but long-term safety data in healthy adults is thin. Melanotan II (MT-2) is a different story. It has never completed Phase 3 trials, is not approved by any major regulatory body, and carries documented cardiovascular and dermatological risks, including reports of melanoma progression in case literature (Lim et al., 2009, Journal of the American Academy of Dermatology).

What did they get wrong (or right)?

There is no spoken claim to directly rebut, which is itself a problem. Vague peptide promotion without context or caveats is misleading by omission. The implicit suggestion that these compounds belong together as a curated "best" list is where this video earns scrutiny.

MT-2 should not be casually hashtagged alongside compounds like GHK-Cu, which has a comparatively benign safety profile. The mechanism of MT-2 is non-selective MC receptor agonism, which is why it causes spontaneous erections and skin darkening but also why it carries unpredictable cardiovascular effects. The FDA has issued warnings about melanotan products sold online. Listing it without any qualifier is irresponsible at a minimum.

If the creator intended this as a general peptide interest post, the hashtag selection still shapes what viewers search for and buy. That is not a technicality, it is how social media health misinformation actually spreads, quietly, through implication.

What should you actually know?

Peptides are not a monolithic category. Some have decades of clinical research behind them. Others are research chemicals that have never been tested in controlled human trials at scale. The distinction matters enormously when you are talking about injecting something into your body.

CJC-1295 and ipamorelin combinations are frequently used in compounded form by anti-aging clinics, but compounded peptides are not equivalent to any FDA-approved drug. Regulatory status varies by country. In the US, several GHRH analogues were removed from the FDA's 503A compounding list in 2023, which affected legal access to CJC-1295 specifically. GHK-Cu in topical form is generally considered low-risk. Injectable GHK-Cu has far less human data. Anyone considering these compounds should be having that conversation with a licensed provider who can review their labs, not getting their stack from a TikTok hashtag list.